摇晃
发表于 2025-3-25 04:41:44
Elisabetta Straface,Lucrezia Gambardella,Marta Brandani,Walter Malorni
白杨
发表于 2025-3-25 11:07:10
http://reply.papertrans.cn/87/8660/865914/865914_22.png
不断的变动
发表于 2025-3-25 12:43:28
Flavia Franconi,Ilaria Campesi,Stefano Occhioni,Paola Antonini,Michael F. Murphy
宫殿般
发表于 2025-3-25 18:08:53
Gerd Glaeske,Cornelia Gerdau-Heitmann,Friederike Höfel,Christel Schicktanz
尊重
发表于 2025-3-25 20:25:17
http://reply.papertrans.cn/87/8660/865914/865914_25.png
APEX
发表于 2025-3-26 03:51:24
http://reply.papertrans.cn/87/8660/865914/865914_26.png
DEMN
发表于 2025-3-26 07:03:37
http://reply.papertrans.cn/87/8660/865914/865914_27.png
无脊椎
发表于 2025-3-26 08:43:55
http://reply.papertrans.cn/87/8660/865914/865914_28.png
ATOPY
发表于 2025-3-26 14:58:57
What a Difference an X or Y Makes: Sex Chromosomes, Gene Dose, and Epigenetics in Sexual Differentia effects of sex chromosome complement (XX vs. XY) and hormonal effects. Several lines of evidence implicate epigenetic processes in the control of sex differences, although a great deal of information is needed about sex differences in the epigenome.
培养
发表于 2025-3-26 19:41:38
Considerations of Sex and Gender Differences in Preclinical and Clinical Trialspecific examples of drugs which have been withdrawn from the market because of side effects in women. Additional information related to sex and gender in preclinical testing, trial design, challenges to recruitment of women for clinical trials and statistical methods for analysis of data also is considered.